Table 1.
Clinical characteristics of patients in the RPVE and RPVE+4 groups
| Characteristic | RPVE | RPVE+4 | P Value |
|---|---|---|---|
| Age, yr | 62 (31-73) | 58 (41-78) | 0.346 |
|
| |||
| Sex, M:F | 11:4 | 47:13 | 0.728 |
|
| |||
| Body height, cm | 176 (158-89) | 175 (150-193) | 0.589 |
|
| |||
| Body weight, kg | 87 (55-116) | 85.2 (49-157) | 0.543 |
|
| |||
| Body mass index, kg/m2 | 28 (21-41) | 27 (19-48) | 0.445 |
|
| |||
| Body surface area, m2 | 2.1 (1.6-2.4) | 2.0 (1.4-2.8) | 0.754 |
|
| |||
| Diabetes mellitus, % of patients | 13 | 19 | 0.611 |
|
| |||
| Etiology, no (%) of patients | 0.068 | ||
| Colorectal mets | 9 (60) | 23 (40) | |
| ICC, HBD, GB | 3 (20) | 18 (31) | |
| HCC | 3 (20) | 4 (7) | |
| Other mets | 0 | 13 (22) | |
|
| |||
| Median interval between PVE and CT (range), days | 27 (14-47) | 27 (9-70) | 0.951 |
mets, metastases; ICC, intrahepatic cholangiocarcinoma; HBD, hilar bile duct cholangiocarcinoma; GB, gallbladder cancer; HCC, hepatocellular carcinoma.